On the showroom floor, we caught up with Tom D’Hoore, the chief commercial officer at HealthTech BioActives (HTBA), to discuss the science-backed benefits of the company’s flavonoid offerings for cardiovascular health and sports nutrition. Intervention studies showed improved arterial flexibility and reduced inflammation in the heart. D’Hoore points out that its flavonoids were shown to increase energy metabolism in amateur athletes. He also discusses current market trends and the importance of sustainability and consumer familiarity.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients















